AI and the Pharmaceutical Industry — 2026-11-13 (Fri)
This section covers corporate investment behaviour of pharmaceutical companies, not the efficacy or safety of any medicinal product. Headlines are quoted as published; no claim about product performance is made or implied by this site. Collection and classification are automated and may misclassify or miss items. Disclaimer
Harvested 464Accepted 5Stale 102Duplicate 60Low-quality source 17Market noise 6Market research 3Off-topic 243No investment signal 24
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
| Amount | Deal | Function | Source |
|---|---|---|---|
| up to $1.5 billion | Blackstone will pay up to $1.5 billion of Pfizer's costs to develop its monthly obesity shot berobenatide | 🏛️ Enterprise AI Platform & Governance | MLQ.ai |
| planned $100 million | Twist Bioscience guides fiscal 2027 revenue to $550-560 million, with $100 million from AI drug discovery | 🧬 Drug Discovery | MLQ.ai |
| $88 million | Generate Biomedicines' quarterly loss widens to $88 million as Phase 3 asthma trials ramp, with cash lasting into 2028 | 🏛️ Enterprise AI Platform & Governance | MLQ.ai |
| $27.5 million | Sahir Raoof launches $27.5 million VC fund betting on AI to reshape pharma services | 🏛️ Enterprise AI Platform & Governance | The American Bazaar |
| $27.5 Million | Proximal Ventures Raises $27.5 Million for AI Drug Development | 🏛️ Enterprise AI Platform & Governance | TOKENPOST |
🧬 Drug Discovery2
- S4 Amount disclosedTwist Bioscience guides fiscal 2027 revenue to $550-560 million, with $100 million from AI drug discoveryplanned $100 million — MLQ.ai11/12 22:07 JST
- S1 DeploymentFRONTEO、AI創薬支援で再生医療のグローバル展開を加速 — ニュースメディアVOIX11/12 16:02 JST
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources1
- S1 Deployment大塚ホールディングスと大塚製薬、生成AI活用を加速するデータガバナンス基盤としてVaronisを採用 — Infoseek11/12 12:45 JSTAlso reported by 1: ライブドアニュース
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance2
- S4 Amount disclosedBlackstone will pay up to $1.5 billion of Pfizer's costs to develop its monthly obesity shot berobenatideup to $1.5 billion — MLQ.ai11/12 20:06 JSTPfizer
- S4 Amount disclosedGenerate Biomedicines' quarterly loss widens to $88 million as Phase 3 asthma trials ramp, with cash lasting into 2028$88 million — MLQ.ai11/12 22:06 JSTGenerate Biomedicines